136 related articles for article (PubMed ID: 16821207)
1. [Percutaneous ethanol injections in the treatment of secondary hyperparathyroidism].
Kuzdak K; Rybińska A; Białas M
Endokrynol Pol; 2005; 56(6):891-6. PubMed ID: 16821207
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism.
Koiwa F; Kakuta T; Tanaka R; Yumita S
Nephrol Dial Transplant; 2007 Feb; 22(2):522-8. PubMed ID: 17127701
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines.
Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
Ther Apher Dial; 2005 Feb; 9(1):48-52. PubMed ID: 15828906
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism.
Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
Nephron Clin Pract; 2006; 102(1):c1-7. PubMed ID: 16166800
[TBL] [Abstract][Full Text] [Related]
5. Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography.
Tanaka R; Kakuta T; Fujisaki T; Tanaka S; Sakai H; Kurokawa K; Saito A
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii58-61. PubMed ID: 12771303
[TBL] [Abstract][Full Text] [Related]
6. [Percutaneous alcohol injection in hyperparathyroidism. Experience in 11 cases with an 18-month follow-up].
Lemmi A; Baroni M; Malaspina C; Rizzo F; Biscarini G; Filipponi P; Gubbiotti G
Radiol Med; 1994 Dec; 88(6):840-3. PubMed ID: 7878245
[TBL] [Abstract][Full Text] [Related]
7. Renoprotection following treatment of secondary hyperparathyroidism with percutaneous ethanol injection in pre-dialysis patients.
Chen HH; Chen YC; Yeh JC
Nephron; 2002 Sep; 92(1):105-10. PubMed ID: 12187092
[TBL] [Abstract][Full Text] [Related]
8. Tertiary hyperparathyroidism treated by ultrasonically guided percutaneous fine-needle ethanol injection.
Cintin C; Karstrup S; Ladefoged SD; Joffe P
Nephron; 1994; 68(2):217-20. PubMed ID: 7830859
[TBL] [Abstract][Full Text] [Related]
9. Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients.
Kitaoka M; Fukagawa M; Ogata E; Kurokawa K
Kidney Int; 1994 Oct; 46(4):1110-7. PubMed ID: 7861705
[TBL] [Abstract][Full Text] [Related]
10. Treatment of uremic hyperparathyroidism with percutaneous ethanol injection.
Fassi J; Lambertini R; Farias P; Blejman O; Rosa Diez G; Algranati S; Plantalech L
Nephron Clin Pract; 2005; 101(2):c53-7. PubMed ID: 15942251
[TBL] [Abstract][Full Text] [Related]
11. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism.
Sanadgol H; Bayani M; Mohammadi M; Bayani B; Mashhadi MA
Iran J Kidney Dis; 2011 Nov; 5(6):410-5. PubMed ID: 22057074
[TBL] [Abstract][Full Text] [Related]
12. Effects of Denosumab and Calcitriol on Severe Secondary Hyperparathyroidism in Dialysis Patients With Low Bone Mass.
Chen CL; Chen NC; Liang HL; Hsu CY; Chou KJ; Fang HC; Lee PT
J Clin Endocrinol Metab; 2015 Jul; 100(7):2784-92. PubMed ID: 25955225
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound in clinical setting of secondary hyperparathyroidism.
Meola M; Petrucci I; Cupisti A
J Nephrol; 2013; 26(5):848-55. PubMed ID: 23042437
[TBL] [Abstract][Full Text] [Related]
14. Decreases in parathyroid gland volume after cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism.
Ichii M; Ishimura E; Okuno S; Chou H; Kato Y; Tsuboniwa N; Nagasue K; Maekawa K; Yamakawa T; Inaba M; Nishizawa Y
Nephron Clin Pract; 2010; 115(3):c195-202. PubMed ID: 20413997
[TBL] [Abstract][Full Text] [Related]
15. Role of the parathyroid gland vascularization index in predicting percutaneous ethanol injection efficacy in refractory uremic hyperparathyroidism.
Chen HH; Lu KC; Lin CJ; Wu CJ
Nephron Clin Pract; 2011; 117(2):c120-6. PubMed ID: 20693813
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of weekly percutaneous maxacalcitol injection therapy in patients with secondary hyperparathyroidism.
Saito A; Matsumoto Y; Oyama Y; Asaka M; Yokoyama H
Ther Apher Dial; 2010 Feb; 14(1):98-103. PubMed ID: 20438525
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism.
Giangrande A; Castiglioni A; Solbiati L; Allaria P
Nephrol Dial Transplant; 1992; 7(5):412-21. PubMed ID: 1321377
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid interventions for secondary hyperparathyroidism in hemodialyzed patients.
Onoda N; Kashiwagi T; Nakamura T; Niitsu Y; Omata M; Kurihara S
Ther Apher Dial; 2005 Aug; 9 Suppl 1():S11-5. PubMed ID: 16109135
[TBL] [Abstract][Full Text] [Related]
19. Time course of change in calcium x phosphorus product after percutaneous ethanol injection therapy.
Koiwa F; Hasegawa T; Kojima I; Ideura T
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii53-7. PubMed ID: 12771302
[TBL] [Abstract][Full Text] [Related]
20. [A case of secondary hyperparathyroidism with an ectopic intrathyroid gland successfully diagnosed and controlled by percutaneous ethanol injection therapy (PEIT)].
Tanaka M; Itoh K; Matsushita K; Ogawa A; Hirayama H; Tsunoda N; Yoshizumi K; Naruse M; Nonoguchi H; Tomita K
Nihon Jinzo Gakkai Shi; 2002 May; 44(4):409-13. PubMed ID: 12073627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
